Virtual Reality for Pediatric Motor Rehabilitation.
Treatment of Balance and Coordination Disorders in the Pediatric Population With the Virtual Reality System Nirvana.
1 other identifier
interventional
50
1 country
3
Brief Summary
Balance and coordination disorders limit the achievement of autonomy in movement and activities of daily living in pediatric population. There are several systems that can be used to treat balance and coordination disorders and those that use virtual reality, such as NIRVANA, are becoming increasingly popular. The primary objective of this post-market clinical investigation is to evaluate the efficacy of the semi-immersive virtual reality platform NIRVANA (BTS Bioengineering), in accordance with the protocol defined at IRCCS Medea in Bosisio Parini, in children with balance and coordination disorders on both motor function and cognitive processes that are indirectly stimulated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
June 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
July 9, 2024
July 1, 2024
15.3 years
October 17, 2023
July 8, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Stabilometry with force platforms
Evaluation of static balance
T0(pre-training),T1 (after 4 weeks of training)
Gross Motor Function Measure-88 (GMFM-88)
Evaluation of the motricity
T0(pre-training),T1 (after 4 weeks of training)
Pediatric Berg Balance Scale (PBBS)
Functional balance
T0(pre-training),T1 (after 4 weeks of training)
Secondary Outcomes (1)
Continuous Performance Test (CPT or KCPT)
T0(pre-training),T1 (after 4 weeks of training)
Study Arms (1)
coordination and balance disorders
EXPERIMENTALSubjects will undergo treatment with NIRVANA lasting 45 minutes for 5 sessions per week for 4 weeks combined with equal dose of task-oriented physiotherapy treatment.
Interventions
NIRVANA is a medical device using semi-immersive virtual reality for motor and cognitive neuro-rehabilitation. NIRVANA creates a "sensory room" where the patient can have an immersive and stimulating experience by interacting directly with different realistic scenarios. The system creates different scenarios on the wall or floor, and the patient interacts with the stimuli provided. A motion-analysis device detects the patient's behavior and based on the projected environment provides highly stimulating and rehabilitative audiovisual feedback with full whole-body immersion. The system is preconfigured with a series of exercises, which can be customized based on different types of patients, intervening on the level of difficulty, speed of execution and sensitive area of the projection.
Eligibility Criteria
You may qualify if:
- balance or coordination disorders of different etiology: tumor, post-traumatic, neurodegenerative, syndromic, congenital, or associated with neurodevelopmental delay. - - - age between 4 and 17 years
- independent ambulation
- ability to understand simple verbal instructions.
You may not qualify if:
- adult
- wheelchair-bound
- major cognitive and behavioural problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Irccs Eugenio Medea
Bosisio Parini, Lecco, 23842, Italy
Irccs Eugenio Medea
Conegliano, Treviso, 31015, Italy
Associazione "La Nostra Famiglia" - Polo Ospedaliero di Neuroriabilitazione, Piazza Di Summa presso ex Complesso Ospedaliero Regionale "A. Di Summa"
Brindisi, 72100, Italy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2023
First Posted
June 10, 2024
Study Start
September 1, 2012
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
July 9, 2024
Record last verified: 2024-07